Summary of Experiences:
Zentalis Pharmaceuticals, NY │Senior Vice-President, Clinical Development May 2023– Dec 2023
Bayer Pharmaceuticals, NJ │Vice-President & Head GMA Oncology Pipeline Jun 2017– Apr 2023
Bayer Pharmaceuticals, NJ │Head of GMA Oncology Pipeline
Novartis Institute of Biomedical Research │Global Clinical Program Leader May 2009 –Jan 2011
AstraZeneca Oncology, UK │Global Brand Physician, Clinical Development Apr 2007 –Apr 2009
AstraZeneca Oncology │Oncology Research Physician, Discovery Medicine Apr 2004 –Mar 2007
Covance Clinical Research Unit, UK │Medical Director Jun 2002 – Mar 2004
Highlight Achievements:
• Investigator for ~ 300 phase 1 studies in healthy volunteers over a 6.5-year period at Covance CRU.
• Contributed to the development of many agents, which are now approved and marketed drugs, such as: Nplate (Amgen), for treating idiopathic thrombocytopenic purpura; Ramelteon (Takeda), for treating insomnia; Udenafil (Daichii), a phosphodieterase 5 inhibitor, for erectile dysfunction; Exenatide (AstraZeneca) for diabetes mellitus; Tekturna (aliskiren, Novartis), a rennin antagonist, for treating hypertension; Tadalafil (Cialis, Lilly) for erectile dysfunction; Artemether-lumefantrine (Coartem, Novartis) for treating malaria; and Sonidegib (Odomzo, Sun Pharma [Novartis]) for the treatment of locally advance or recurrent BCC.
• Honorary Lecturer, University of Leeds (1998-2003) for Certificate in Clinical Research course.
Education and Professional Qualifications
• Executive Management Education @ Harvard Business School: Strategic Agility, September 13-24, 2021.
• Executive Management Education @Harvard Business School: Disruptive Innovation, July 9-14, 2018.
• General Medical Council (UK) Registration
Limited Registration: June 1993 to June 1997
Full Registration (Principal List): since 11 June 1997
• Specialist Register (Pharmaceutical Medicine): since 22 August 2008
• Elected Fellow, Faculty of Pharmaceutical Medicine (FFPM, June 2008)
• Completed Specialist Training in Pharmaceutical Medicine (UK, Jan 2008)
• Diploma in Pharmaceutical Medicine (UK, 2000)
• Completed Modular course in Pharmaceutical Medicine, University of Wales, UK (2000)
• Diploma in Child Health (DCH), Royal College of Paediatrics & Child Health (UK, 1997)
• MB ChB, University of Ghana Medical School (1985-1991)
• President, Ghana Medical Students’ Association (1989/90)
• Presby. Boys’ Sixth Form Science College, Legon, Ghana (1982-1984); GCE Advanced Level:
Mathematics (A), Chemistry (A) and Physics (A)